Magnetic and Biocompatible Polyurethane Nanofiber Biomaterial for Tissue Engineering

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cardiovascular Engineering

Background:

• Cardiovascular device surfaces face challenges like thrombosis and neointimal hyperplasia.
• Current cell targeting strategies often lack specificity for in vivo applications.
• Superparamagnetic iron oxide nanoparticles offer potential for targeted cell localization.

Purpose of the Study:

• To develop a magnetic polyurethane (PU)-2205 stainless steel (2205-SS) nanofibrous composite biomaterial.
• To evaluate the material's properties and its efficacy in magnetic cell capture for stent-graft applications.
• To assess the cytocompatibility of the novel composite material.

Main Methods:

• Electrospinning of PU and 2205-SS microparticles at varying ratios (0-4:1).
• Fabrication of stent-grafts with magnetic or nonmagnetic stents using the optimal composite ratio (2:1).
• Characterization via microscopy, mechanical testing, sessile drop test, magnetic field measurement, cell capture assays, and 14-day endothelial cell culturing.

Main Results:

• An optimal 2:1 2205-SS:PU ratio yielded a hydrophobic material with balanced mechanical and magnetic properties.
• The composite material demonstrated cytocompatibility with endothelial cells for up to 14 days.
• Significant cell capture was achieved with a 0.5 mm thick material, and magnetic stent-grafts showed uniform cell distribution.

Conclusions:

• The developed magnetic PU-2205 SS nanofibrous composite is a promising biomaterial for cardiovascular applications.
• The material enables site-specific magnetic capture of endothelial cells and potentially other therapeutic agents.
• This technology holds potential for advancing vascular and tissue engineering applications through improved device integration and cell targeting.